miR-31 functions as an oncogene in cervical cancer
暂无分享,去创建一个
[1] S. Steinberg,et al. Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer , 2014, Journal of Translational Medicine.
[2] A. Pivarcsi,et al. MicroRNA-31 Is Overexpressed in Cutaneous Squamous Cell Carcinoma and Regulates Cell Motility and Colony Formation Ability of Tumor Cells , 2014, PloS one.
[3] S. Lei,et al. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells , 2014, Oncology letters.
[4] Hui Li,et al. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. , 2014, Gynecologic oncology.
[5] Li Li,et al. MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2 , 2014, Archives of Gynecology and Obstetrics.
[6] X. Wan,et al. Interferon-β Induced microRNA-129-5p Down-Regulates HPV-18 E6 and E7 Viral Gene Expression by Targeting SP1 in Cervical Cancer Cells , 2013, PloS one.
[7] Wei Huang,et al. miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1 , 2013, Experimental and therapeutic medicine.
[8] D. Yao,et al. Aberrant expression of miR-20a and miR-203 in cervical cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[9] Sheng Wang,et al. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer , 2013, Clinical and Translational Oncology.
[10] Lei Yang,et al. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. , 2013, International journal of oncology.
[11] Stefan Wiemann,et al. MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)* , 2013, The Journal of Biological Chemistry.
[12] C. C. Sage,et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis , 2013, Oncogene.
[13] Menghong Sun,et al. A pri-miR-218 variant and risk of cervical carcinoma in Chinese women , 2013, BMC Cancer.
[14] David I. Smith,et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm , 2012, Cell cycle.
[15] Zhongqiu Lin,et al. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. , 2012, Biochimica et biophysica acta.
[16] Zhongqiu Lin,et al. Aberrant microRNA expression in human cervical carcinomas , 2012, Medical Oncology.
[17] Li-ping Guo,et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. , 2011, Clinical science.
[18] T. Kwok,et al. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway , 2011, Oncogene.
[19] Li-Min Feng,et al. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. , 2011, Gynecologic oncology.
[20] A. Jemal,et al. Global Cancer Statistics , 2011 .
[21] Ming Yi,et al. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts , 2010, Cell cycle.
[22] Lan Xu,et al. miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.
[23] E. Dmitrovsky,et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.
[24] L. Laimins,et al. Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins , 2010, Journal of Virology.
[25] Joseph O Deasy,et al. A microRNA expression signature for cervical cancer prognosis. , 2010, Cancer research.
[26] W. Lv,et al. Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection , 2010, International Journal of Gynecologic Cancer.
[27] T. Brunner,et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. , 2009, Cancer research.
[28] R. Swaminathan,et al. Prognostic significance of HPV physical status and integration sites in cervical cancer. , 2009, Asian Pacific journal of cancer prevention : APJCP.
[29] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[30] Mauro Biffoni,et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.
[31] S. Le,et al. Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth , 2008, PloS one.
[32] F. Monzon,et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells , 2008, Oncogene.
[33] Yitzhak Pilpel,et al. Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer , 2006, Clinical Cancer Research.